XOMA Corp (XOMA)

Currency in USD
39.57
-0.14(-0.37%)
Real-time Data·
Earnings results expected in 10 days
XOMA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
39.1840.50
52 wk Range
20.9540.74
Key Statistics
Prev. Close
39.71
Open
39.72
Day's Range
39.18-40.5
52 wk Range
20.95-40.74
Volume
51.53K
Average Volume (3m)
241.86K
1-Year Change
87.4882%
Book Value / Share
6.77
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XOMA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
65.75
Upside
+66.16%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

XOMA Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

XOMA Corp Earnings Call Summary for Q4/2025

  • XOMA Q4 2025 EPS of $0.26 beat forecast of -$0.11 by 336%; revenue reached $13.76M, exceeding estimates by 23.63%
  • Full-year revenue surged 82.8% vs 2024; GAAP net income of $31.7M reversed prior year's $13.8M loss; royalty receipts up 68% to $34M
  • Stock climbed 5.19% to $28.40 in pre-market trading following the earnings beat, reflecting strong investor confidence
  • Company projects continued growth in 2026 driven by diversified portfolio and strategic capital deployment initiatives
  • Key risks include ongoing Janssen Biotech litigation and declining cash reserves from strategic investments despite debt reduction efforts
Last Updated: 03/18/2026, 10:18 PM
Read Full Transcript

Compare XOMA to Peers and Sector

Metrics to compare
XOMA
Peers
Sector
Relationship
P/E Ratio
25.4x6.1x−0.5x
PEG Ratio
0.14−0.690.00
Price/Book
5.6x3.7x2.6x
Price / LTM Sales
9.0x11.4x3.2x
Upside (Analyst Target)
46.1%68.4%44.2%
Fair Value Upside
Unlock9.9%5.5%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 65.75
(+66.16% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Leerink Partners
Buy50.00+26.07%45.00MaintainFeb 24, 2026
TD Cowen
Hold---New CoverageFeb 12, 2026
Leerink Partners
Buy45.00+13.46%-MaintainDec 31, 2025
Benchmark
Buy50.00+26.07%50.00MaintainDec 12, 2025
H.C. Wainwright
Buy97.00+144.58%104.00MaintainDec 11, 2025

Earnings

Latest Release
Mar 18, 2026
EPS / Forecast
0.26 / -0.11
Revenue / Forecast
13.76M / 11.13M
EPS Revisions
Last 90 days

XOMA Income Statement

People Also Watch

43.07
FLY
-1.50%
12.535
RCAT
-1.45%
10.575
ONDS
+5.75%
19.550
AMPX
+4.71%
37.130
PL
-3.51%

FAQ

What Is the XOMA (XOMA) Stock Price Today?

The XOMA stock price today is 39.57 USD.

What Stock Exchange Does XOMA Trade On?

XOMA is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for XOMA?

The stock symbol for XOMA is "XOMA."

What Is the XOMA Market Cap?

As of today, XOMA market cap is 471.74M USD.

What Is XOMA's Earnings Per Share (TTM)?

The XOMA EPS (TTM) is 1.46.

When Is the Next XOMA Earnings Date?

XOMA will release its next earnings report on Apr 30, 2026.

From a Technical Analysis Perspective, Is XOMA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has XOMA Stock Split?

XOMA has split 2 times.

How Many Employees Does XOMA Have?

XOMA has 14 employees.

What is the current trading status of XOMA (XOMA)?

As of Apr 20, 2026, XOMA (XOMA) is trading at a price of 39.57 USD, with a previous close of 39.71 USD. The stock has fluctuated within a day range of 39.18 USD to 40.50 USD, while its 52-week range spans from 20.95 USD to 40.74 USD.

What Is XOMA (XOMA) Price Target According to Analysts?

The average 12-month price target for XOMA is 65.75 USD, with a high estimate of 97 USD and a low estimate of 50 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +66.16% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.